- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06120192
Examining the Effect of Piano Playing Training on Fine Motor Skills in Parkinson's Patients
November 1, 2023 updated by: Jason Friedman, Tel Aviv University
Piano playing may provide an engaging and accessible setting for finger and wrist movement training.
Moreover, it has been found effective for improving manual dexterity and upper-limb function in other neurologic disorders, such as stroke and additionally beneficial for cognitive and psychosocial support in Parkinson's disease.
However, no study has examined the effect of piano playing on dexterity in Parkinson's disease.
The aim of this study is to test the efficacy of a novel piano-based training program on fine motor function in patients with PD.
Participants with Parkinson's disease will take part in an individually tailored 6-week piano training program, combining weekly supervised training sessions (6x60 min altogether), with three independent at-home weekly 30 minutes practice sessions (18x30 altogether).
Participants will receive a piano MIDI keyboard for home use during the study.
Study Overview
Study Type
Interventional
Enrollment (Actual)
3
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tel Aviv, Israel, 6997801
- Tel Aviv University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Idiopathic Parkinson's Disease patients
- Hoehn and Yahr stages I to III
- Self-reports of some dexterity difficulties
Exclusion Criteria:
- Participation in an ongoing clinical study or clinical study within 30 days prior to this study
- Atypical parkinsonian syndrome or secondary parkinsonism (e.g., due to drugs, metabolic neurogenetic disorders, encephalitis, cerebrovascular disease, or other degenerative disease), or other neurologic conditions influencing upper limb movement
- Significant psychiatric symptoms or history
- Significant or recent experience in piano playing (participants who are proficient piano players, or had studied piano for more than 3 years in the past, or for shorter periods in the last 5 years)
- Other significant fine motor skills (e.g., high proficiency in playing another musical instrument, video games, etc.)
- Mini Mental status examination (MMSE) score below 25
- Significant sensory deficits, e.g., hearing or sight impairment
- Unstable medical disorder
- Significant postural or action tremor, moderate dyskinesia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Research group
Receives the full piano training
|
Receives the piano training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Box and block test
Time Frame: First meeting, last meeting (after 6 weeks)
|
Number of blocks that can be moved over a barrier using the hand / arm in one minute
|
First meeting, last meeting (after 6 weeks)
|
|
9 Hole peg test
Time Frame: First meeting, last meeting (after 6 weeks)
|
Time taken to insert 9 pegs into holes and then remove them
|
First meeting, last meeting (after 6 weeks)
|
|
Synergy index
Time Frame: First meeting, last meeting (after 6 weeks)
|
Calculated from a force ramp production task using the fingers with force sensors
|
First meeting, last meeting (after 6 weeks)
|
|
Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) motor parts II (patient questionnaire) - parts 2.4 to 2.7 and III (motor examination) - parts 3.3 and 3.4
Time Frame: First meeting, last meeting (after 6 weeks)
|
Standard questionnaire used in Parkinson's disease.
Higher scores indicate more impairment.
Maximum score for each part is 4, so overall for the 6 parts the maximum score is 24.
|
First meeting, last meeting (after 6 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quantitative Digitography - Average strike duration
Time Frame: First meeting, last meeting (after 6 weeks)
|
Measure of speed and variability of key presses on a piano - mean of the time the key is pressed
|
First meeting, last meeting (after 6 weeks)
|
|
Quantitative Digitography - Coefficient of variation strike duration
Time Frame: First meeting, last meeting (after 6 weeks)
|
Measure of speed and variability of key presses on a piano - coefficient of variation of the time the key is pressed
|
First meeting, last meeting (after 6 weeks)
|
|
Quantitative Digitography - Average interval between strikes (in seconds)
Time Frame: First meeting, last meeting (after 6 weeks)
|
Measure of speed and variability of key presses on a piano - average time between subsequent key presses
|
First meeting, last meeting (after 6 weeks)
|
|
Quantitative Digitography - Coefficient of variation of interval between strikes
Time Frame: First meeting, last meeting (after 6 weeks)
|
Measure of speed and variability of key presses on a piano - coefficient of variation of the time between subsequent key presses
|
First meeting, last meeting (after 6 weeks)
|
|
Quantitative assessment of piano performance progress
Time Frame: First meeting, last meeting (after 6 weeks)
|
Measurement of improvement in playing the piano - the teacher (rater) will give a score (between 0 and 5) for the level of piano playing of the participant, where 0 is no ability to play and 5 is the ability to play the pieces from the workbook (a beginner's level piano book) perfectly.
|
First meeting, last meeting (after 6 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 22, 2022
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
October 26, 2023
First Submitted That Met QC Criteria
November 1, 2023
First Posted (Actual)
November 7, 2023
Study Record Updates
Last Update Posted (Actual)
November 7, 2023
Last Update Submitted That Met QC Criteria
November 1, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 8407-21-SMC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Anonymous raw data from the tests will be made available on figshare
IPD Sharing Time Frame
Upon publication
IPD Sharing Access Criteria
Open to all
IPD Sharing Supporting Information Type
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
-
ProgenaBiomeWithdrawnParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
Clinical Trials on Piano
-
Westminster CollegeCompletedAging | Manual Dexterity | Piano TherapyUnited States
-
Recep Tayyip Erdogan University Training and Research...CompletedDental Anxiety in ChildrenTurkey (Türkiye)
-
Reuth Rehabilitation HospitalUniversity of HaifaRecruitingHemiparesis;Poststroke/CVAIsrael
-
University of GeorgiaApplied Universal Dynamics, Corp.; Van Robotics, Inc.Active, not recruitingRobot-assisted Cognitive Training for Lonely Older Adults With Mild Cognitive Impairment (MCI) (MCI)Cognitive Change | Aging | Cognitive Impairment, MildUnited States
-
University of MiamiCompletedBreast Cancer | Chemotherapy-Related Cognitive ImpairmentUnited States
-
University of MiamiTerminatedDepression | Mood | Burden, DependencyUnited States
-
University of RochesterEastman Performing Arts Medicine Center; University of Rochester Aging Institute and other collaboratorsCompletedMild Cognitive Impairment (MCI) | Memory Decline | Memory Disorders, Age RelatedUnited States
-
University of California, San FranciscoNational Institute on Aging (NIA)CompletedCognitive Impairment | Aging | Mild Cognitive Impairment | Cognitive Training | Cognitive Aging | Cognitively Normal Older AdultsUnited States
-
Ondokuz Mayıs UniversityNot yet recruitingRespiration DisordersTurkey
-
University of California, San FranciscoNational Institute on Aging (NIA)Active, not recruitingCognitive Impairment | Aging | Mild Cognitive Impairment | Cognitive Training | Cognitive Aging | Cognitively Normal Older AdultsUnited States